Hot Topics

SKYRIZI® (risankizumab-rzaa) Receives FDA Approval

Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron

FDA Approves First Systemic Treatment for Alopecia Areata

Nurse Leader Fundamentals: On-Demand Workshop and Tools Package